Spots Global Cancer Trial Database for A Study of Epoetin Beta (NeoRecormon) in Participants With Solid Tumors
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Study of Epoetin Beta (NeoRecormon) in Participants With Solid Tumors
Official Title: An Open-Label Study of the Safety Of NeoRecormon in Patients With Solid Tumors Being Treated With Platinum Capable of Inducing Anemia
Study ID: NCT02554942
Conditions
Interventions
Study Description
Brief Summary: This study will evaluate the safety of subcutaneous (SC) epoetin beta (NeoRecormon) in adults with solid tumors being treated with platinum-based chemotherapy capable of inducing anemia. The anticipated time on study treatment is 16 weeks, and the target sample size is approximately 208 individuals.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
, Alcoy, , Spain
, Barakaldo, , Spain
, Barcelona, , Spain
, Barcelona, , Spain
, Barcelona, , Spain
, Caceres, , Spain
, El Palmar Murcia, , Spain
, La Laguna, , Spain
, Manresa, , Spain
, Salamanca, , Spain
, Valencia, , Spain
, Valencia, , Spain
, Zaragoza, , Spain
Contact Details
Name: Clinical Trials
Affiliation: Hoffmann-La Roche
Role: STUDY_CHAIR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
